We’re Celebrating a Milestone Year
2025 marks 30 years of The American Journal of Managed Care®. To commemorate this milestone, we’re sharing even more valuable content, from exclusive interviews and insights from thought leaders to facts and figures on our 3 decades of impact.
Latest News
View All
Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies
Understanding gMG: Autoantibodies and Life-Altering Muscle Weakness
In Charleston, West Virginia, Tracking MPN Symptoms Becomes a Priority
FDA Approves Datopotamab Deruxtecan for HR-Positive/HER2-Negative Metastatic Breast Cancer
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
Increased Interest in Advance Provision and Over-the-Counter Medication Abortion
Building Trust Through Community Engagement in Cancer Care
Nearly One-Third of Americans Face Unregulated Contaminants in Water, Hispanic, Black Communities Hit Hardest
Economic Data Show Cost-Effectiveness of Statin, Antihypertensive Polypill for CVD in Low-Income Populations
Updated Guidelines Allow Men Who Have Sex With Men to Join National Blood Donor Month Efforts
Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy
Lung Cancer Screening Facilities Least Accessible to American Indian/Alaska Native Patients, Rural Communities
Ethnic Disparities Identified in Colorectal Cancer Diagnoses, Study Finds
Designing Care for the Underserved Creates Higher-Value Health Solutions
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
MAIC Analyses and Bispecific Therapies: Guiding Treatment Decisions in B-Cell Lymphomas
Economic Implications of Diagnostic Delays in Hidradenitis Suppurativa
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Insights on Allogeneic Hematopoietic Cell Transplantation: Values of Older Adult Patients
ASH 2024 Highlights: Bispecifics in Combination Therapies for B-Cell Lymphomas
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Integrating Emerging BTKi Therapies Into Current Treatment Guidelines
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Diagnosis and Common Comorbidities Seen With Iron Deficiency Anemia
Innovations in Breast Cancer Treatment With Dr Dawn Klemow
Choosing an Initial Therapy for Alopecia Areata
Deciding When to Treat Patients With Alopecia Areata
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
Association Between Screening for Suspected COVID-19 Cases and Outcomes of Patients Revisiting the Emergency Department
BeiGene’s Mehrdad Mobasher, MD, MPH, Discusses CLL Data, Pipeline Following ASH 2024
The High Cost of Shortages of Low-Cost Chemotherapy
Navigating Persistent Financial Toxicity in the Patient Experience
SPOTLIGHT: “I Didn’t Go to Med School to Learn How to Save People Money”
SPOTLIGHT: Sarah Hogue, PharmD, on Expanding the Role of Oncology Pharmacists
A Standardized Care Pathway Increases Optimal Dialysis Starts
Uptake of Rituximab Biosimilars in Medicare and Medicaid in 2019-2022
Managed Care Approaches to Improve Outcomes in Frontline Therapy for Renal Cell Carcinoma
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
Desmoid Tumors: What Managed Care Professionals Need to Know to Manage These Unpredictable Tumors, featuring a Pharmacy Focus Podcast
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
